Haematology News and Research

RSS

Research reveals why stem cell transplants are so successful in MS patients

Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study led by the University of Zurich has now examined in detail the way in which the treatment curbs the autoimmune disease and how the immune system regenerates afterwards.

10 Nov 2022

Study elucidates mechanism that is crucial for making hemophilia therapy effective

Hemophilia A is the most common severe form of hemophilia. It affects almost exclusively males. The disease can usually be treated well, but not for all sufferers.

27 Oct 2022

AI model could be used to enable more effective care for skin cancer patients

The artificial intelligence model could be utilized to enable more effective care for skin cancer patients and could lead to similar breakthroughs in the diagnosis and treatment of other cancers.

7 Oct 2022

Routine newborn screening for sickle cell disease urgently needed to save lives in Africa

More than 300,000 babies globally are born every year with sickle cell, a hereditary condition which causes red blood cells to become sickle-shaped.

5 Oct 2022

PhoreMost enters multi-project drug target discovery collaboration with Roche

PhoreMost to deploy its SITESEEKER platform to identify novel targets for Roche’s discovery programmes

From PhoreMost 6 Sep 2022

Review may lead to improvements in therapeutic options for preterm infants

One in two premature babies receives transfusions of red blood cells (RBC) due to anemia. There are no generally accepted clinical guidelines for the degree of anemia necessitating blood transfusions.

26 Jul 2022

Researchers explore disease severity post-infection with SARS-CoV-2 Omicron in hematologic patients

A new study has studied the clinical outcome and spectrum in 61 patients infected with the SARS-CoV-2 Omicron variant.

29 Jun 2022

Novel app can help doctors make better decisions for patients with leukemia.

Researchers at the University of Copenhagen and clinicians at Rigshospitalet have developed an app that can help doctors make better decisions for patients with leukemia.

24 Jun 2022

New combination of drugs effective against T-cell acute lymphoblastic leukemia

Acute lymphoblastic leukemia (ALL) is the most common cancer affecting children. The T-ALL form of leukemia that emerges from early T lineage cells has a poorer prognosis than B-lineage ALL. The prognosis for relapsed T-ALL is very poor and new therapies are sorely needed.

20 Jun 2022

AI tool allows clinicians to make optimal, personalized chemotherapy doses for patients

A team of researchers from National University of Singapore, in collaboration with clinicians from the National University Cancer Institute, Singapore which is part of the National University Health System (NUHS), has reported promising results in using CURATE.AI, an artificial intelligence (AI) tool that identifies and better allows clinicians to make optimal and personalized doses of chemotherapy for patients.

13 Jun 2022

Scientists unlock the cellular secrets of aging process

New research has uncovered how genetic changes that accumulate slowly in blood stem cells throughout life are likely to be responsible for the dramatic change in blood production after the age of 70.

1 Jun 2022

Innovative Augmented Reality Joint Scanner unveiled at Westmead Children's Hospital to support young people with hemophilia

An Australian-designed, first-of-its-kind Augmented Reality technology has been unveiled today at The Children’s Hospital at Westmead (CHW). The technology will enable young people living with Hemophilia to view the potentially irreversible impact of disabling joint disease.

31 May 2022

Study shows link between abnormal blood clotting and impaired exercise capacity in people with long COVID

According to a study published today in Blood Advances, people suffering from long COVID may face an increased risk of abnormal blood clotting.

11 May 2022

Novel magnetic therapy complements chemotherapy to enhance breast cancer treatment outcomes

Breast cancer is the leading cause of cancer-associated death for women worldwide. While chemotherapy is the mainstream treatment for breast cancer, more than 50% of women undergoing chemotherapy will experience at least one chemotherapy-related adverse side effect.

3 May 2022

Haematology News and Research

Research reveals why stem cell transplants are so successful in MS patients

Study elucidates mechanism that is crucial for making hemophilia therapy effective

AI model could be used to enable more effective care for skin cancer patients

Routine newborn screening for sickle cell disease urgently needed to save lives in Africa

PhoreMost enters multi-project drug target discovery collaboration with Roche

Review may lead to improvements in therapeutic options for preterm infants

Researchers explore disease severity post-infection with SARS-CoV-2 Omicron in hematologic patients

Novel app can help doctors make better decisions for patients with leukemia.

New combination of drugs effective against T-cell acute lymphoblastic leukemia

AI tool allows clinicians to make optimal, personalized chemotherapy doses for patients

Scientists unlock the cellular secrets of aging process

Innovative Augmented Reality Joint Scanner unveiled at Westmead Children's Hospital to support young people with hemophilia

Study shows link between abnormal blood clotting and impaired exercise capacity in people with long COVID

Novel magnetic therapy complements chemotherapy to enhance breast cancer treatment outcomes

Study uncovers blood clotting and immune protein pathways impacted in children with severe COVID-19

UNIGE scientists develop a novel tool to visualize palmitoylation process in living cells

Unique immune cell fingerprint can help rapidly identify better treatment for autoimmune disease

HORIBA introduces network option for digital morphology training tool for multiple user access in multiple locations

HORIBA introduces network option for digital morphology training tool for multiple user access in multiple locations

Optical genome mapping holds potential to become an important component of leukemia diagnostics

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News